Financial Market News

Apollo is buying into a wealth firm that borrowed to pay its owners, Zelle picked Solana for a stablecoin, and bigger-hike bets faded.

MARKET PULSE

Bonds Eased. Chips Fell Anyway.

Nvidia reports after the close into a market that has lost patience with AI stocks. The 10-year Treasury yield fell 3 basis points to 5.12% on Monday. Stocks fell anyway. The S&P 500 closed down 1.9%, and the Nasdaq lost 2.5%. Chipmakers led the way down.

Both indexes have now fallen three days in a row, and stock futures edged higher early Tuesday, so the selling has paused. Rate bets cooled on Monday too. On Kalshi, the contract on a December hike larger than a quarter point slid to about 6 cents from 9 by the close. The quarter-point contract rose to 91 cents. Cleveland Fed President Beth Hammack said Monday she prefers smaller steps. October retail sales arrive this morning.

Investor Signal

Lower yields usually lift growth stocks, so Monday's drop points to doubts about AI earnings, not rates. Earnings now carry the valuations alone. A strong retail sales report that lifts the bigger-hike contract back above 10 cents would put borrowing costs back at the center of the selling.

PREMIER FEATURE

The AI Trade Is Changing. Are You Holding the Wrong Stocks?

The biggest AI stocks just suffered a brutal sell-off. But AI isn't over the opportunity is shifting.

Discover how you can get positioned to profit from the next phase of the AI supercycle before Wall Street catches on.

Click here to learn more

NVIDIA WATCH

Nvidia's Board Built an Export Committee

Nvidia's board moved on compliance before its first report without Jensen Huang. Nvidia (NVDA) set up a new board committee Tuesday. It will oversee export controls and national security. Director Suzanne Nora Johnson will chair it. The company's compliance teams will now report to the committee and to interim chief Colette Kress, which puts export risk under direct board watch.

It follows Treasury Secretary Scott Bessent's 10-day demand for compliance answers. The board is not considering bringing Huang back, a Monday report said. The stock fell 4.1% Monday to $156.14.

Nvidia guided to about $108 billion in quarterly revenue, which excludes data-center sales to China, and analysts expect about $109 billion. Options price a move of about 7% to 9%.

Investor Signal

The committee makes export compliance a standing board job. It can shrink the governance discount, but it cannot answer the demand question. A firm outlook with no customer or shipment under review would leave the selloff looking like a discount the board can remove. A compliance-related sales pause would turn that risk into lost revenue.

AI FUNDING WATCH

Nscale's Sales Grew 14-Fold. It Needs More Money.

AI's builders can sign contracts faster than they can fund them. Nscale is a British data-center operator planning a New York listing. Its amended IPO filing says it "will be required to obtain additional financing" for 2027. In September, it said it was funded for at least a year.

Preliminary figures put revenue at $307.5 million for the first nine months, up from $21.3 million a year earlier, while the loss reached $1.69 billion. Debt rose to about $5.52 billion.

Nscale counts up to about $44.6 billion of work for Anthropic. Its Microsoft (MSFT) work orders were signed for up to $43.8 billion. One worth $3.22 billion has since been terminated. It also ordered Nvidia (NVDA) chips for the Anthropic work, yet it has no binding commitments to finance that build.

Investor Signal

Some of Nvidia's sales depend on buyers like Nscale raising money first. That makes their financing terms an early read on chip demand. Signed financing for the Anthropic work would show lenders fund AI backlogs. A deep cut to its IPO valuation, or debt on harsh terms, would show the funding chain tightening one step before Nvidia.

FROM OUR PARTNERS

Jim Rickards Predicts: Trump's Next Big Buy

This tiny $2 stock holds the exclusive rights to the largest gold reserve in the country.

And it has the potential to be the biggest fortune maker in Trump’s second term.

According to Jim Rickards...

Trump is about to take a direct stake in this $2 stock.

And if you’d like to learn how to stake your claim in this asset before President Trump and his administration make a move…

You need to act now.

Click here to see Jim’s big prediction: “Trump’s Next Big Buy.”

IRAN ODDS WATCH

Traders Bet on Restraint as Ships Are Hit

Prediction markets are pricing American restraint. That is a narrower bet than peace. Polymarket's contract on a two-week pause in U.S. strikes on Iran rose to nearly 80 cents early Tuesday. It was near 70 cents at Monday's close. It pays on a 14-day strike pause that starts by month-end.

The move came as President Trump left for Asia and Iran's foreign minister held talks in Oman. Iran's Revolutionary Guards said their drones targeted a U.S. radar in Bahrain. Bahrain said Tuesday it intercepted them. Another tanker was disabled near Hormuz late Monday, a maritime agency said. Oil was already pricing a supply surplus. Brent settled down 3.6% Monday at $92.44.

Investor Signal

Oil and the restraint bet lean the same way, which eases one source of the inflation the Fed is fighting. The bet rests on Washington choosing not to strike. The attack in Bahrain tests that choice. A U.S. strike on Iranian soil would reset the contract's clock. A confirmed hit on Saudi export routes would test the surplus case.

PRIVATE CAPITAL WATCH

Apollo Buys Into a Firm That Borrowed to Pay Owners

Private owners are bringing in new money without giving up control. Funds managed by Apollo Global Management (APO) agreed to invest in Focus Financial Partners, a wealth-management platform. A report put the undisclosed sum near $2.5 billion.

That is close to what Focus has paid its owners since August 2024 with borrowed money, rating-agency figures show. Focus is rated B, a speculative grade. Its debt is projected at seven to eight times earnings. The money will not pay down debt, CEO Adam Birenbaum told a trade publication. Focus has not said whether any of it will reach its owners.

Investor Signal

Steady advisory fees can still draw minority money. With debt paydown ruled out, leverage stays near seven to eight times earnings unless the new money lifts earnings. Deals that add profit would bring that ratio down. A payout to the owners would leave it in place.

PARTNER SPOTLIGHT

Shock Prediction: “The Majority of Investors Could Soon Become Millionaires”

For the first time in over a century, the dollar is collapsing. Meanwhile, stocks keeping hitting new records. What’s going on? One expert says we’re on the brink of a crisis no American alive today has ever seen.

The time it occurred; every investor became a millionaire—but at a terrible cost. For the full story, click here.

STABLECOIN WATCH

Zelle Chose Solana, on a Test Network

Big banks are moving payments toward public blockchains, but slowly. Zelle, the payments network they own, said its dollar stablecoin will run on Solana, starting with a U.S.-to-India route targeted for the end of 2026. It set no firm launch date. Its demo ran on a test network, and it moved $1.25 million with the amount hidden from the public.

The token is small, with about 138,000 on-chain at the start of November, by one count. Zelle handled more than $1.2 trillion in payments in 2025. Intercontinental Exchange (ICE) may become a Solana validator, an executive said.

Investor Signal

For banks, the hidden amount may matter more than the chain, because regulated lenders are generally unwilling to show payment sizes on a public ledger. At scale, banks could move dollars on public chains privately. A launch date with named banks would show the plan is moving. A slip past the year-end target would leave it a test.

CLOSING LENS

Money and permission are still available to AI and to steady businesses, but whoever supplies them is setting terms. Washington wants compliance answers from Nvidia. Nscale's lenders have yet to commit to its biggest build. Apollo is taking a slice of Focus. Tonight's results show whether AI demand is strong enough to meet those terms.

AI Moves Into the Biotech Lab

For most of the AI boom, the money followed the hardware. Chips. Data centers. Cloud.
Now the algorithms are walking into the lab.
In September, a drug whose target was found by AI, and whose molecule was designed by AI, dosed its first patient in a Phase III trial. A second AI-engineered medicine is in Phase III too.
We profiled the 5 companies leading the shift in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.

Get the Free Report by Text →